chrM-12297-T-C
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The ENST00000000000(TRNL2):c.32T>C(p.Leu11Pro) variant causes a missense change. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
ENST00000000000 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000387456.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MT-TL2 | ENST00000387456.1 | TSL:6 | n.32T>C | non_coding_transcript_exon | Exon 1 of 1 | ||||
| MT-ND5 | ENST00000361567.2 | TSL:6 | c.-40T>C | upstream_gene | N/A | ENSP00000354813.2 | |||
| MT-ND4 | ENST00000361381.2 | TSL:6 | c.*160T>C | downstream_gene | N/A | ENSP00000354961.2 |
Frequencies
Mitomap
ClinVar
Submissions by phenotype
Cardiomyopathy, mitochondrial Pathogenic:1
MELAS syndrome Benign:1
The NC_012920.1:m.12297T>C variant in MT-TL2 gene is interpreted to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes reported in the guidelines: BS1, BS2
not provided Other:1
Variant interpretted as Uncertain significance and reported on 04/12/2017 by GTR ID MNG Laboratories. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.
Computational scores
Source: